177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
about
Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide TherapyNeuroblastoma and nephroblastoma: a radiological reviewGa-68 DOTATATE positron emission tomography/computer tomography in initial staging and therapy response evaluation in a rare case of primary neuroblastoma in neck2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.Positron emission tomography image-guided drug delivery: current status and future perspectives.Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes.Surgical resection and post-operative radiotherapy in an adult renal neuroblastoma patient with multiple bone and joint metastases: A case report.Advances in Risk Classification and Treatment Strategies for Neuroblastoma.The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursRadionuclide therapy of adrenal tumors.Ten challenges in the management of neuroblastoma.Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.Nuclear medicine and multimodality imaging of pediatric neuroblastoma.Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.MRI Contrast Agents for Pharmacological Research.Somatostatin receptor positron emission tomography/computed tomography (PET/CT) in the evaluation of opsoclonus-myoclonus ataxia syndrome.Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.Radiation exposure to comforters and carers during paediatric molecular radiotherapy.Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.Could 68Ga-somatostatin analogues be an important alternative to 18F-DOPA PET/CT in pediatrics?Challenging Management of Neuroendocrine Tumor With Hepatic Metastasis and Carcinoid Heart Disease in a Child.Neuroblastoma: clinical and biological approach to risk stratification and treatment.PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors
P2860
Q26773377-3191BF60-07F6-461B-944A-CE12601CA01CQ26861867-84B6C712-3831-418A-9014-5308F20500BEQ34147065-1EA249AC-E4A8-48EE-B029-08C272758763Q34404416-A9348C90-76B2-4E58-8126-2C26A7CB531BQ34446108-CDE2CAA5-3B7D-4FA5-B497-57C0BE243F43Q35288725-5FA80B61-568D-4808-A8D0-E96D5CB47095Q35758527-049E6D3B-201C-4EC4-9257-A3B67532F282Q36053801-2A14DC6F-3E9F-4F90-A522-7F297CEF0196Q36755905-E620E4D8-86B5-49B6-9E3E-7ED83E966856Q38020428-8D7DBAB7-5CBB-490A-A13E-45259CFDABACQ38029366-D7D0D602-7AE6-4AF3-ADD6-7C6995013C1FQ38054112-55950A20-C5F6-470E-BDD9-FC09A3044A06Q38059788-DFD4A29C-FA97-4222-99DB-57B14DE2BD81Q38659292-68C287BA-272E-4FF7-9DF4-9F2E66BCC818Q38804821-E3442621-4312-4920-AB78-34B78F6A80D2Q42084719-73168FDF-2F05-4ADB-9EB9-716242DD5D67Q42690843-117AACDB-D8AF-4315-B03A-791F022725A6Q43376054-84E002F2-3814-4256-BDF8-D6342972F4B6Q46286336-E5A32F7A-FF0D-427A-8FCD-F8B9906001C9Q47771714-29AB1C3A-C545-4099-B911-B4C9A57DDB8DQ48226465-4E88408E-273F-4B85-BF8E-98E90CDF6E22Q51366001-73A480F6-2D1C-4D2C-BB14-0D7B78A5D29FQ52639269-9DEF15EE-A28A-40B8-86BB-D473C0115994Q59074896-C9E77A11-0660-4CAA-9A01-5FB97B58FF8E
P2860
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@ast
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@en
type
label
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@ast
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@en
prefLabel
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@ast
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@en
P2093
P1476
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
@en
P2093
Derek D'Souza
Jamshed B Bomanji
Jennifer E Gains
Kevin P Sullivan
Matthew Aldridge
Naomi L Fersht
Tracy Sullivan
Wendy Waddington
P304
P356
10.2967/JNUMED.110.085100
P407
P50
P577
2011-06-16T00:00:00Z